FDA.reportPublic FDA data

MAGNESIUM CARBONATE

Substance profile for UNII 0E53J927NA, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for MAGNESIUM CARBONATE
Structure render from PubChem CID 71376

Substance Identity#

UNII
0E53J927NA
Preferred term
MAGNESIUM CARBONATE
Registry number
17968-26-2
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
CO3.Mg.H2O
Chemical structure for MAGNESIUM CARBONATE
Structure render from PubChem CID 71376

Chemical And Database Identifiers#

InChIKey
OUHCLAKJJGMPSW-UHFFFAOYSA-L
SMILES
O.[Mg++].[O-]C([O-])=O
RxCUI
29155
PubChem
71376
NCIt
C66048
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem Compound71376pubchem.ncbi.nlm.nih.gov/compound/71376
PubChem InChIKey SearchOUHCLAKJJGMPSW-UHFFFAOYSA-Lpubchem.ncbi.nlm.nih.gov/#query=OUHCLAKJJGMPSW-UHFFFAOYSA-L
RxNorm29155mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=29155
NCI ThesaurusC66048ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C66048
FDA Substance Registration System0E53J927NAprecision.fda.gov/uniisearch/srs/unii/0E53J927NA

DailyMed Socrata Ingredients#

Type, DailyMed label, SPL version table
TypeDailyMed labelSPL version
INACTIVE INGREDIENTLANSOPRAZOLE7
INACTIVE INGREDIENTQuinapril Hydrochloride and Hydrochlorothiazide Tablets, USP Rx Only8
INACTIVE INGREDIENTQuinapril Tablets, USP Rx only4
ACTIVE INGREDIENTAllergies: Fruits and Vegetables1
ACTIVE INGREDIENTEmvita 251
ACTIVE INGREDIENTEmvita 211
ACTIVE INGREDIENTEmvita 191
INACTIVE INGREDIENTThese highlights do not include all the information needed to use PREVACID safely and effectively. See full prescribing information for Prevacid: PREVACID (lansoprazole) delayed-release capsules, for oral use PREVACID SoluTab (lansoprazole) delayed-release orally disintegrating tablets, for oral use Initial U.S. Approval: 19951000
ACTIVE INGREDIENTTinnitus Relief™1
INACTIVE INGREDIENTAtenolol Tablets, USP4
ACTIVE INGREDIENTHeartburn Relief™2
ACTIVE INGREDIENTExtra Strength Foamcoat Antacid Tablets1
ACTIVE INGREDIENTEar Ringing™1
INACTIVE INGREDIENTDRUG FACTS1
INACTIVE INGREDIENTQuinapril Hydrochloride Tablets2
INACTIVE INGREDIENTQuinapril Hydrochloride Tablets2
INACTIVE INGREDIENTQuinapril Hydrochloride Tablets2
ACTIVE INGREDIENTBowel - Digestive Care1
ACTIVE INGREDIENTNausea1
ACTIVE INGREDIENTMagneBind 400 Rx magnesium carbonate, calcium carbonate, folic acid tablet, coated3
ACTIVE INGREDIENTMagneBind 400 Rx magnesium carbonate, calcium carbonate, folic acid tablet, coated2
INACTIVE INGREDIENTAtenolol Tablets, USP5
INACTIVE INGREDIENTAtenolol Tablets, USP2
INACTIVE INGREDIENTThese highlights do not include all the information needed to use lansoprazole delayed-release capsules safely and effectively. See full prescribing information for: LANSOPRAZOLE delayed-release capsules USP For oral administration Initial U.S. Approval: 19951
ACTIVE INGREDIENTEar Ringing Symptom Formula™1
INACTIVE INGREDIENTDrug Facts3
ACTIVE INGREDIENTSohMed™ Acid Reducer1
INACTIVE INGREDIENTdc18a886-8376-40e8-b460-926cd8baf49d1
INACTIVE INGREDIENTNeutrogena Healthy Skin 3-in-1 Concealer for Eyes Sunscreen Broad Spectrum SPF 201
ACTIVE INGREDIENTAcid Free-Flux1
INACTIVE INGREDIENTDRUG FACTS1
ACTIVE INGREDIENTEYE - CATARACT1
ACTIVE INGREDIENTCONSTIPATION1
INACTIVE INGREDIENTQUINAPRIL TABLETS, USP, 5 mg, 10 mg, 20 mg, and 40 mg 1050 1051 1045 1053 Rx only2
INACTIVE INGREDIENTDrug Facts2
ACTIVE INGREDIENTINSOMNIA HP1
INACTIVE INGREDIENTThese highlights do not include all the information needed to use lansoprazole delayed-release capsules safely and effectively. See full prescribing information for: LANSOPRAZOLE delayed-release capsules USP For oral administration Initial U.S. Approval: 19951
INACTIVE INGREDIENTDrug Facts7
INACTIVE INGREDIENTDrug Facts4
INACTIVE INGREDIENTAtenolol Tablets, USP3
INACTIVE INGREDIENTThese highlights do not include all the information needed to use lansoprazole safely and effectively. See full prescribing information for: Lansoprazole Delayed-Release Capsules, USP For oral administration Initial U.S. Approval: 19951
ACTIVE INGREDIENTHeartburnCare1
INACTIVE INGREDIENTSPAI-SONS TALCO FINO / POWDER FINE TALCUM1
INACTIVE INGREDIENTThese highlights do not include all the information needed to use lansoprazole delayed-release capsules USP safely and effectively. See full prescribing information for lansoprazole delayed-release capsules USP. LANSOPRAZOLE delayed-release capsules USP for oral use Initial U.S. Approval: 19951
INACTIVE INGREDIENTLansoprazole Delayed-Release Capsules USP, 15 mg2
INACTIVE INGREDIENTAtenolol Tablets, USP2
ACTIVE INGREDIENTAttention and Learning Enhancement3
INACTIVE INGREDIENTThese highlights do not include all the information needed to use DEXILANT safely and effectively. See full prescribing information for DEXILANT. DEXILANT (dexlansoprazole) delayed-release capsules, for oral use Initial U.S. Approval: 1995 (lansoprazole)2
ACTIVE INGREDIENTMenopause-HF1
INACTIVE INGREDIENTAtenolol Tablets, USP1
INACTIVE INGREDIENTThese highlights do not include all the information needed to use lansoprazole delayed-release capsules USP safely and effectively. See full prescribing information for lansoprazole delayed-release capsules USP. LANSOPRAZOLE delayed-release capsules USP for oral use Initial U.S. Approval: 19954
INACTIVE INGREDIENTAtenolol Tablets, USP1
INACTIVE INGREDIENTThese highlights do not include all the information needed to use Lansoprazole Delayed-Release Capsules and Lansoprazole Delayed-Release Orally Disintegrating Tablets safely and effectively. See full prescribing information for: Lansoprazole Delayed-Release Capsules Lansoprazole Delayed-Release Orally Disintegrating Tablets For oral administration Initial U.S. Approval: 19952
INACTIVE INGREDIENTAtenolol Tablets, USP1
INACTIVE INGREDIENTa6eab450-f4c1-4e3d-adc5-7f656d4f6df61
INACTIVE INGREDIENT7c9030df-5bb8-48bd-bcee-75d11f8a91801
INACTIVE INGREDIENT9eabd702-68e2-40bb-b227-e85cb2b894e31
INACTIVE INGREDIENTdd90124a-3c26-41e7-966b-73ff3b7f03ac1
INACTIVE INGREDIENT57e43263-4f38-4744-90f7-4c0daef80aff1
INACTIVE INGREDIENT854c800d-c0bd-4316-85b3-aabfa735ca821
INACTIVE INGREDIENTd5876848-1de3-481a-aa94-a0db7598da7b1
INACTIVE INGREDIENTa3160155-75ed-4668-ac8b-57c5da57ee721
INACTIVE INGREDIENT56671fc8-c904-4999-b880-db4997447d911
INACTIVE INGREDIENT6225caf8-dec2-4e7a-a325-8f56171a65301
INACTIVE INGREDIENTd3e0991b-ae92-4cff-b508-daee3b037a3f1
INACTIVE INGREDIENTdbff9d17-31b5-4ea2-8d73-fe08fbaf59ec1
INACTIVE INGREDIENT9b5901bb-188a-470c-9aae-1b37b664f0e61
INACTIVE INGREDIENT370084dd-835b-4839-9fa8-45055a4543691
INACTIVE INGREDIENTcfec6231-b076-4b8a-9b37-6047ac29a5361
INACTIVE INGREDIENT46ff3175-a52a-4be1-991c-ed48496206aa1
INACTIVE INGREDIENTe65994c0-e828-44a9-98eb-04e1ed7e14bf1
INACTIVE INGREDIENT5aa13f23-73cc-4208-ba8c-b1ba68b1e0921
INACTIVE INGREDIENTAtenolol Tablets, USP1
ACTIVE INGREDIENT"Drug Facts"1
INACTIVE INGREDIENTAtenolol tablets4
INACTIVE INGREDIENTAtenolol tablets1
INACTIVE INGREDIENTAtenolol 25 mg1
ACTIVE INGREDIENTInsomnia Plus1
ACTIVE INGREDIENTConnective Tissue5
ACTIVE INGREDIENTGastritis - Ulcer3
ACTIVE INGREDIENTRestless Leg3
ACTIVE INGREDIENTDigestive Care2
INACTIVE INGREDIENTATENOLOL TABLETS, USP1
ACTIVE INGREDIENTConnective Tissue1
ACTIVE INGREDIENTDigestive Care1
ACTIVE INGREDIENTGas - Indigestion1
ACTIVE INGREDIENTGas Indigestion1
ACTIVE INGREDIENTGastritis - Ulcer1
ACTIVE INGREDIENTRestless Leg1
ACTIVE INGREDIENTToothache Complex1
INACTIVE INGREDIENTcd68370f-2e0d-48b2-837e-6cab17cfe0562
INACTIVE INGREDIENT96a218a6-4c84-4a04-b592-2aa2319dcbcb2
INACTIVE INGREDIENT1c8add00-1ca7-41ce-9e9b-e4e3d467ae762
INACTIVE INGREDIENTb303e7dc-1d5e-4feb-833e-c8a4b1f020d22
INACTIVE INGREDIENTde3be509-33e7-4897-b6db-c66f1ea9cb621
INACTIVE INGREDIENT63b0795d-9ed1-44f8-a27e-9464825ab4bb1
INACTIVE INGREDIENT04dbb59b-47ad-4bb7-a449-15d9b24c75191
INACTIVE INGREDIENTe0b1dfd5-a3d0-4ea2-9135-9b2d06b254161
INACTIVE INGREDIENTafea11ee-6dc6-4884-9a93-7071f995864b1
INACTIVE INGREDIENT7851de58-cb08-424d-ab6e-97e526d7ba731
INACTIVE INGREDIENT7e8857bd-2b86-44d2-9bb0-4c28350934861
INACTIVE INGREDIENT70b78d2b-1106-4ba2-8fec-583337be0c131
INACTIVE INGREDIENT81173721-b759-4529-9f10-5ff7cedb98c11
INACTIVE INGREDIENT6646b5f6-6752-49f3-93b6-a6bf9cfdf0641
INACTIVE INGREDIENT37575749-4d7d-4648-bfc4-0fbdd5e4927e1
INACTIVE INGREDIENTe22bd726-f68a-4570-8088-81937a9851121
INACTIVE INGREDIENT64b4c89a-8ddd-456c-8450-3c24d9c07ffa1
INACTIVE INGREDIENTba455d7a-d567-48b3-9cff-07ceace36a7e1
INACTIVE INGREDIENTe5a76e08-c5fd-46fc-906b-880069f66ec41
INACTIVE INGREDIENT6a3cd443-4f0a-4906-8c27-2610a104b8cf1
INACTIVE INGREDIENT56bf1b0a-463a-4324-957b-585d4cf352ee1
ACTIVE INGREDIENTBowel - Digestive Care1
ACTIVE INGREDIENTBowel - Digestive Care1
ACTIVE INGREDIENTDiarrhea1
ACTIVE INGREDIENTDiarrhea1
ACTIVE INGREDIENTMorning Sickness1
ACTIVE INGREDIENTSwimmers Support1
ACTIVE INGREDIENTSwimmers Support1
INACTIVE INGREDIENTQUINAPRIL TABLETS USP 5 mg, 10 mg, 20 mg and 40 mg1
INACTIVE INGREDIENTQuinapril Tablets, USP6

Inactive Ingredient Database#

Browse recovered IID releases and source provenance.

Current IID rows for UNII 0E53J927NA page 1 of 1 · 12 matching rows.

Ingredient, UNII, CAS table
IngredientUNIICASDosage formRoutePotencyMaximum daily exposure
MAGNESIUM CARBONATE0E53J927NA17968262CAPSULEORAL22.4 mg
MAGNESIUM CARBONATE0E53J927NA17968262CAPSULE, COATED PELLETSORAL22.4 mg
MAGNESIUM CARBONATE0E53J927NA17968262CAPSULE, DELAYED RELEASEORAL180 mg
MAGNESIUM CARBONATE0E53J927NA17968262CAPSULE, EXTENDED RELEASEORAL180 mg
MAGNESIUM CARBONATE0E53J927NA17968262TABLETORAL500 mg
MAGNESIUM CARBONATE0E53J927NA17968262TABLET, CHEWABLEORAL100 mg
MAGNESIUM CARBONATE0E53J927NA17968262TABLET, COATEDORAL28.5 mg
MAGNESIUM CARBONATE0E53J927NA17968262TABLET, DELAYED RELEASEORAL250 mg
MAGNESIUM CARBONATE0E53J927NA17968262TABLET, EXTENDED RELEASEORAL11.22 mg
MAGNESIUM CARBONATE0E53J927NA17968262TABLET, FILM COATEDORAL500 mg
MAGNESIUM CARBONATE0E53J927NA17968262TABLET, ORALLY DISINTEGRATINGORAL120 mg
MAGNESIUM CARBONATE0E53J927NA17968262TABLET, ORALLY DISINTEGRATING, DELAYED RELEASEORAL84 mg